BioPharm International, January 2013 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, January 2013
Online Exclusive
The Future Quality Laboratory
By Angie Drakulich
A recent ISPE guidance provides a baseline for the design of quality laboratory facilities.
Features
The Future of Biopharma
By Eric S. Langer
What the industry's future holds and what needs to be done to get there.
A Look Ahead at BioPharma Manufacturing and Regulation
By Angie Drakulich
FDA talks about the changing scope of regulatory science.
Epigenetics Drives Pharma Innovation
By K. John Morrow, Jr., PhD
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.
Bioconjugates: The Adaptable Challenge
By Trishul Shah
Conjugation of a biologic to a carrier molecule can solve problems in solubility and stability, but introduces its own challenges.
Biologics: What Does the Future Hold?
Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.
Polishing Complex Therapeutic Proteins
By Min Lin, PhD , Nathalie Frau, PhD , Rene Faber, PhD , Ashley Hesslein, PhD , Jens H. Vogel, PhD
A new downstream purification platform using a salt-tolerant membrane adsorber.
From the Editor
A Look Ahead in Biomanufacturing
By Angie Drakulich
Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
Global Reports
Report from Brazil
By Hellen Berger
Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.
Regulatory Beat
Drug Quality at Center Stage for FDA and Manufacturers
By Jill Wechsler
Shortages spur efforts to overhaul manufacturing oversight.
European Beat
Falsified Medicines Directive Takes Shape in Europe
By Sean Milmo
The EU fine-tunes the Falsified Medicines Directive.
Perspectives on Outsourcing
Offshoring Biomanufacturing
By Eric S. Langer
Will international biomanufacturing outsourcing become mainstream in this decade?
Burrill on Biotech
Accelerating Change Marks 2012 for Life Sciences
By G. Steven Burrill
A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.
Boot Camp Technical Guide
Aseptic Processing: A Primer
NIBRT's Ray O'Connor provides an overview of aseptic processing.

ADVERTISEMENT

ADVERTISEMENT

Click here